China grants its first COVID-19 vaccine patent to CanSino

  •  China has for the first time patented their Corona vaccine Ad5-nCOV.

China grants its first COVID-19 vaccine patent to CanSino ( Ad5-nCOV ) 1
China’s first patent for COVID-19 vaccine has been granted on August 11, according to State Intellectual Property Administration

 

              China grants its first COVID-19 vaccine patent to CanSino ( Ad5-nCOV ), according to People’s Daily reports, developed by Chenwei and CanSino Biologics Inc., citing documents from the China’s National Intellectual Property Regulator. The application for the patent was submitted on March 18 and is currently being approved on August 11, the report says. 

China grants its first COVID-19 vaccine patent to CanSino ( Ad5-nCOV )
China grants country’s first Corona vaccine patent to CanSino Biologics Inc.,

 

This is the first time China grants its first COVID-19 vaccine patent to CanSino, state newspaper People’s Daily reported on Sunday.

Saudi Arabia has announced that it will begin Phase III of clinical human trials for the Cansino vaccine this month. Cansino says talks are underway in Russia, Brazil and Chile to conduct the third phase of the CanSino vaccine in human trials.

0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
close
0
Would love your thoughts, please comment.x
()
x